The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories, AbbVie Inc., Alvogen Iceland ehf, and more among key companies- Technavio



NEW YORK, Sept. 24, 2023 /PRNewswire/ — The thyroid gland disorder treatment market is expected to grow by USD 868.87 million from 2022 to 2027. In addition, the growth momentum of the market will progress at a CAGR of 5.33% during the forecast period, according to Technavio. The rise in…

Leave a Reply